Semaglutide
Long-acting GLP-1 receptor agonist for metabolic research
Semaglutide
Semaglutide is a GLP-1 receptor agonist research peptide. It regulates glucose-dependent insulin secretion and suppresses appetite through hypothalamic signaling. Widely investigated in models of obesity and metabolic resistance.
A long-acting GLP-1 receptor agonist studied for glucose-dependent insulin secretion and appetite regulation.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications. Purchase requires valid research credentials.
Purity
Purity Exceeds 99%
Storage
2–8°C
Form
Lyophilized
Grade
Research
Semaglutide Overview
A long-acting GLP-1 receptor agonist studied for glucose-dependent insulin secretion and appetite regulation.
Specifications
| Composition | Semaglutide |
|---|---|
| Molecular Formula | C187H291N45O59 |
| Half-Life | ~165 hours (≈7 days) |
| Purity | Purity Exceeds 99% |
| Available Sizes | 10mg, 30mg |
| Storage | 2–8°C, protect from light |
| SKU | SM10 |
| Grade | Research / Laboratory use only |



